Literature DB >> 1691592

Different Epstein-Barr virus expression in lymphomas from immunocompromised and immunocompetent patients.

B Borisch-Chappuis1, C Nezelof, H Müller, H K Müller-Hermelink.   

Abstract

Eighteen tissue samples from lymphoproliferative lesions and lymphomas in immunodeficiency states were investigated for their content of Epstein-Barr virus (EBV) genome by dot blotting and for the distribution of EBV in tissue sections by in situ hybridization. Fourteen lymphomas from AIDS patients and four children with disorders of the immune system were available. For control reasons, six cases of infectious mononucleosis (IM) and eight Burkitt's lymphomas (BL) from malaria-free regions of Africa were included in the study. Two different patterns of EBV distribution are described: 1) heterogeneous scattered EBV-positive cells, as originally seen in IM and therefore called the IM-type pattern, 2) and a BL-type pattern seen in endemic Burkitt's lymphoma with homogeneous EBV-positive cells all over the tumor. In lymphomas in patients with inborn immunodeficiencies, an IM-type pattern was found. In lymphomas from AIDS patients, the two different patterns were found. There were lymphomas with the IM-type pattern as well as some with the BL-type pattern. In some AIDS-associated lymphomas, both patterns occurred in one tumor. The findings suggest that it is not the disease process that is the distinguishing feature between the two patterns of EBV infection but rather the patient's underlying disease and the extent of this disease.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Biology; Case Histories; Data Collection; Diseases; Examinations And Diagnoses; Histology; Hiv Infections; Immunity; Immunologic Factors; Laboratory Examinations And Diagnoses; Physiology; Research Methodology; Viral Diseases

Mesh:

Substances:

Year:  1990        PMID: 1691592      PMCID: PMC1877655     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  Lymphadenopathy in renal transplant patients treated with immunosuppressive antibodies (OKT3 and anti-thymocyte globulin). A report of nine cases.

Authors:  D Canioni; P MacKelvie; A Debure; C Nezelof
Journal:  Am J Surg Pathol       Date:  1989-02       Impact factor: 6.394

Review 2.  Viral latency and transformation: the strategy of Epstein-Barr virus.

Authors:  G Klein
Journal:  Cell       Date:  1989-07-14       Impact factor: 41.582

3.  Epstein-Barr virus-associated lymphoproliferative disorder. Applications of immunoperoxidase and molecular biologic techniques.

Authors:  M J Kornstein; J Weber; J B Luck; G V Massey; S Strom; N B McWilliams
Journal:  Arch Pathol Lab Med       Date:  1989-05       Impact factor: 5.534

4.  Purification of DNA from formaldehyde fixed and paraffin embedded human tissue.

Authors:  S E Goelz; S R Hamilton; B Vogelstein
Journal:  Biochem Biophys Res Commun       Date:  1985-07-16       Impact factor: 3.575

5.  Southern blot analysis of DNA extracted from formalin-fixed pathology specimens.

Authors:  L Dubeau; L A Chandler; J R Gralow; P W Nichols; P A Jones
Journal:  Cancer Res       Date:  1986-06       Impact factor: 12.701

6.  Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas.

Authors:  L Zech; U Haglund; K Nilsson; G Klein
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

7.  Malignant lymphomas in a population at risk for acquired immune deficiency syndrome.

Authors:  T Ahmed; G P Wormser; R E Stahl; R Mamtani; J Cimino; M Glasser; A Mittelman; M Friedland; Z Arlin
Journal:  Cancer       Date:  1987-08-15       Impact factor: 6.860

8.  The clinico-pathological expressions of Epstein-Barr virus infection in lymphoid tissues.

Authors:  G Frizzera
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1987

9.  EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients.

Authors:  G Klein; E Svedmyr; M Jondal; P O Persson
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

10.  In situ demonstration of Epstein-Barr viral genomes in viral-associated B cell lymphoproliferations.

Authors:  L M Weiss; L A Movahed
Journal:  Am J Pathol       Date:  1989-03       Impact factor: 4.307

View more
  12 in total

1.  Detection of Epstein-Barr virus genome in Ki-1 (CD30)-positive, large-cell anaplastic lymphomas using the polymerase chain reaction.

Authors:  C W Ross; J A Schlegelmilch; T M Grogan; L M Weiss; B Schnitzer; C A Hanson
Journal:  Am J Pathol       Date:  1992-08       Impact factor: 4.307

Review 2.  Lymphoproliferative disease in organ transplant recipients.

Authors:  M A Nalesnik
Journal:  Springer Semin Immunopathol       Date:  1991

Review 3.  X-linked lymphoproliferative disease (XLP) as a model of Epstein-Barr virus-induced immunopathology.

Authors:  D T Purtilo
Journal:  Springer Semin Immunopathol       Date:  1991

4.  Epstein-Barr virus and brain lymphomas.

Authors:  R M Bashir; F H Hochberg; M X Wei
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

5.  Expression of bcl-2 and p53 proteins in nasopharyngeal carcinoma. Absence of correlation with the presence of EBV encoded EBER1-2 transcripts and latent membrane protein-1.

Authors:  C Kouvidou; P Kanavaros; D Papaioannou; E Stathopoulos; F Sotsiou; G Datseris; M Tzardi; C Kittas; G Delides
Journal:  Clin Mol Pathol       Date:  1995-02

6.  Detection of Eber-1 RNA in primary brain lymphomas in immunocompetent and immunocompromised patients.

Authors:  R Bashir; B McManus; C Cunningham; D Weisenburger; F Hochberg
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Enteropathy-associated T-cell lymphoma in a renal transplant patient with evidence of Epstein-Barr virus involvement.

Authors:  B Borisch; I Hennig; F Horber; K Bürki; J Laissue
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 8.  Molecular pathology of AIDS-related lymphomas. Biologic aspects and clinicopathologic heterogeneity.

Authors:  G Gaidano; C Pastore; C Lanza; U Mazza; G Saglio
Journal:  Ann Hematol       Date:  1994-12       Impact factor: 3.673

9.  Lymphoproliferative disease in mice infected with murine gammaherpesvirus 68.

Authors:  N P Sunil-Chandra; J Arno; J Fazakerley; A A Nash
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

10.  Epstein-Barr virus and HIV play no direct role in persistent generalized lymphadenopathy syndrome.

Authors:  M J Boyle; T B Sculley; D A Cooper; J J Turner; R Penny; W A Sewell
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.